PT Kimia Farma (Persero) Tbk (KAEF):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:PT Kimia Farma (Persero) Tbk (KAEF) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11532
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インドネシア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PT Kimia Farma (Persero) Tbk (Kimia Farma) manufactures, commercializes and distributes pharmaceutical products. The company provides ethical (prescription), generic and other products. It offers products in various categories including alimentary system, allergy and immune system, system anaesthetic, local and general antibiotic, antidotes and detoxifying, cardiovascular and hematopoietic, dermatological, eye and ear, genito – urinary system, hormones, intravenous and other sterile, metabolism, neuromuscular, other chemoterapetics, respiratory, vitamin and minerals and others. Kimia Farma distributes its products in various countries across the world including Asia, Europe and Africa. The company operates manufacturing plants in Jakarta, Bandung, Semarang, Watudakon, Medan and West Java. Kimia Farma is headquartered in Jakarta, Indonesia.

PT Kimia Farma (Persero) Tbk (KAEF) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
PT Kimia Farma Forms Joint Venture with PT Sungwun Pharmacopia Indonesia 10
PT Kimia Farma Enters Into Joint Venture Agreement With PT Tigaka Distrindo And Tianjin Pharma Group 11
Debt Offering 12
PT Kimia Farma to Raise USD43.5 Million in Public Offering of 7.75% Notes Due 2021 12
PT Kimia Farma Plans to Raise USD17 Million in Public Offering of Notes 13
PT Kimia Farma (Persero) Tbk – Key Competitors 14
PT Kimia Farma (Persero) Tbk – Key Employees 15
PT Kimia Farma (Persero) Tbk – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Joint Venture 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare, Key Facts, 2017 2
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PT Kimia Farma (Persero) Tbk, Deals By Therapy Area, 2012 to YTD 2018 8
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PT Kimia Farma Forms Joint Venture with PT Sungwun Pharmacopia Indonesia 10
PT Kimia Farma Enters Into Joint Venture Agreement With PT Tigaka Distrindo And Tianjin Pharma Group 11
PT Kimia Farma to Raise USD43.5 Million in Public Offering of 7.75% Notes Due 2021 12
PT Kimia Farma Plans to Raise USD17 Million in Public Offering of Notes 13
PT Kimia Farma (Persero) Tbk, Key Competitors 14
PT Kimia Farma (Persero) Tbk, Key Employees 15
PT Kimia Farma (Persero) Tbk, Other Locations 16
PT Kimia Farma (Persero) Tbk, Subsidiaries 16
PT Kimia Farma (Persero) Tbk, Joint Venture 17

List of Figures
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PT Kimia Farma (Persero) Tbk, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[PT Kimia Farma (Persero) Tbk (KAEF):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TPI Composites Inc (TPIC):企業の財務・戦略的SWOT分析
    TPI Composites Inc (TPIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Oglethorpe Power Corporation:企業の発電所・SWOT分析2018
    Oglethorpe Power Corporation - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Probi AB (PROB):製薬・医療:M&Aディール及び事業提携情報
    Summary Probi AB (Probi) is a biotechnology company develops, produces and markets probiotics. The company offers licenses for its technology and sells finished products in bulk. It focuses on products for the improvement of gastrointestinal health and immune system. It distributes its products to l …
  • Petro Caribbean Resources Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Petro Caribbean Resources Ltd (Petro Caribbean Resources) is an oil and gas exploration and development company that offers oil and gas exploration and development of petroleum and natural gas reserves. The company owns and operates oil and gas assets located in Putumayo Basin, Colombia. It …
  • Ricoh Company, Ltd. (7752):企業の財務・戦略的SWOT分析
    Ricoh Company, Ltd. (7752) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Epic Systems Corp:企業の戦略的SWOT分析
    Epic Systems Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • China North Industries Corporation:企業の戦略・SWOT・財務情報
    China North Industries Corporation - Strategy, SWOT and Corporate Finance Report Summary China North Industries Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Cytox Ltd-医療機器分野:企業M&A・提携分析
    Summary Cytox Ltd (Cytox) is a diagnostic and prognostic service provider that develops services for neurodegenerative disorders. The company’s blood tests are used to predict, which patients with MCI will develop Alzheimer's disease. Its biomarkers are based on the cell cycle hypothesis of Alzheime …
  • African Phoenix Investments Limited:企業の戦略・SWOT・財務情報
    African Phoenix Investments Limited - Strategy, SWOT and Corporate Finance Report Summary African Phoenix Investments Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • SurgaColl Technologies Ltd:製品パイプライン分析
    Summary SurgaColl Technologies Ltd (SurgaColl Technologies) is a medical device company that develops regenerative technologies. The company’s products comprise hydroxycoll and chondrocoll. It offers regenerative solutions in the field of bone, cartilage and osteochondral tissue regeneration. SurgaC …
  • HealthCare Global Enterprises Ltd (HCG):製薬・医療:M&Aディール及び事業提携情報
    Summary HealthCare Global Enterprises Ltd (HCG), formerly Curie Centre of Oncology Private Ltd is a healthcare service provider that provides medical care and treatment services. The company provides services such as clinical laboratory services, diagnosis services, medical oncology services, radiat …
  • Greentech Energy Systems AS (GES)-エネルギー分野:企業M&A・提携分析
    Summary Greentech Energy Systems AS (Greentech) is an energy company which operates renewable energy plants. It generates electricity from wind and solar sources. Through long-term power purchase agreements, the company sells electricity. Greentech expands its asset portfolio through inorganic growt …
  • Clean Harbors, Inc. (CLH):企業の財務・戦略的SWOT分析
    Clean Harbors, Inc. (CLH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Japan Foods Co Ltd:企業の戦略・SWOT・財務情報
    Japan Foods Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Japan Foods Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Graham Group Ltd:企業の戦略・SWOT・財務情報
    Graham Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Graham Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • NYU Langone Medical Center:製薬・医療:M&Aディール及び事業提携情報
    Summary NYU Langone Medical Center (NYU LMC) a subsidiary of New York University School of Medicine is an academic healthcare center that provides patient care, education and research services. The center offers patient care services such as patient and family support; imaging services, medical serv …
  • Sebia SA:医療機器:M&Aディール及び事業提携情報
    Summary Sebia SA (Sebia) is a medical device company that designs, manufactures, commercializes, and exports electrophoresis tests and analyzers. The company's electrophoresis program offers automated system for capillary electrophoresis, gel electrophoresis and electrophoresis scanning software. It …
  • EVN AG:発電所・企業SWOT分析
    EVN AG - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives) …
  • Tokyo Electron Ltd (8035):企業の財務・戦略的SWOT分析
    Tokyo Electron Ltd (8035) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Jet Airways (India) Ltd.:企業の戦略・SWOT・財務情報
    Jet Airways (India) Ltd. - Strategy, SWOT and Corporate Finance Report Summary Jet Airways (India) Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆